Qure.ai
Its chest X-ray analysis AI tool is the first to receive Europe's clearance for use in children aged 0-3.
        
        
          40% of their time is spent on manually collecting data, which the tool would assist in reducing.
 
        
        
          Also, Mediwhale raised $12 million for its United States expansion.
        
        
          Also, Qure.ai has obtained breakthrough device designation for its tuberculosis AI.
        
        
          Also, Qure.ai has received its 13th FDA approval for its AI-based medical imaging software. 
        
        
          They will deploy AI to help reduce delays and gaps in stroke care management.
        
        
          Qure.ai's qXR software will enable Mylab's upcoming x-ray device to quickly detect TB.
        
        
          Also, AIRS Medical has proved the capability of its AI MRI reconstruction tool to denoise and improve the quality of 3D MR images.
        
        
          Also: Digital mental health company Brightside Health scores $50 million, and Qure.ai brings in $40 million for its imaging algorithms.
        
        
          Also, HCA Healthcare UK opens £26M specialist oncology unit at UCLH.
        
        
           
 
 
 
 
 
 
